Category Archives: Biology/Health

Magnesium – and Defficiency – NIH

Introduction

Assessing magnesium status

Recommended Intakes

Table 1 lists the current RDAs for magnesium [1]. For infants from birth to 12 months, the FNB established AIs for magnesium that are equivalent to the mean intake of magnesium in healthy, breastfed infants, with added solid foods for ages 7 to 12 months.

AgeMaleFemalePregnancyLactation
0–6 months30 mg*30 mg*
7–12 months75 mg*75 mg*
1–3 years80 mg80 mg
4–8 years130 mg130 mg
9–13 years240 mg240 mg
14–18 years410 mg360 mg400 mg360 mg
19–30 years400 mg310 mg350 mg310 mg
31–50 years420 mg320 mg360 mg320 mg
51+ years420 mg320 mg

Download this table as a CSV file

*Adequate Intake (AI)

Sources of Magnesium

Food

FoodMilligrams
(mg) per
serving
Percent
DV*
Pumpkin seeds, roasted, 1 ounce15637
Chia seeds, 1 ounce11126
Almonds, dry roasted, 1 ounce8019
Spinach, boiled, ½ cup7819
Cashews, dry roasted, 1 ounce7418
Peanuts, oil roasted, ¼ cup6315
Cereal, shredded wheat, 2 large biscuits6115
Soymilk, plain or vanilla, 1 cup6115
Black beans, cooked, ½ cup6014
Edamame, shelled, cooked, ½ cup5012
Peanut butter, smooth, 2 tablespoons4912
Potato, baked with skin, 3.5 ounces4310
Rice, brown, cooked, ½ cup4210
Yogurt, plain, low fat, 8 ounces4210
Breakfast cereals, fortified with 10% of the DV for magnesium, 1 serving4210
Oatmeal, instant, 1 packet369
Kidney beans, canned, ½ cup358
Banana, 1 medium328
Milk, 1 cup276
Salmon, Atlantic, farmed, cooked, 3 ounces266
Halibut, cooked, 3 ounces246
Raisins, ½ cup235
Bread, whole wheat, 1 slice235
Avocado, cubed, ½ cup225
Chicken breast, roasted, 3 ounces225
Beef, ground, 90% lean, pan broiled, 3 ounces205
Broccoli, chopped and cooked, ½ cup123
Rice, white, cooked, ½ cup102
Apple, 1 medium92
Carrot, raw, 1 medium72

Download this table as a CSV file

Dietary supplements

Medicines

Magnesium is found in some remedies for heartburn and acid indigestion, and it is a key ingredient in certain laxatives.

Magnesium Intakes and Status

Magnesium Deficiency

Groups at Risk of Magnesium Inadequacy

References

  1. Institute of Medicine (IOM). Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC: National Academy Press, 1997.
  2. Rude RK. Magnesium. In: Coates PM, Betz JM, Blackman MR, Cragg GM, Levine M, Moss J, White JD, eds. Encyclopedia of Dietary Supplements. 2nd ed. New York, NY: Informa Healthcare; 2010:527-37.
  3. Rude RK. Magnesium. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, eds. Modern Nutrition in Health and Disease. 11th ed. Baltimore, Mass: Lippincott Williams & Wilkins; 2012:159-75.
  4. Volpe SL. Magnesium. In: Erdman JW, Macdonald IA, Zeisel SH, eds. Present Knowledge in Nutrition. 10th ed. Ames, Iowa; John Wiley & Sons, 2012:459-74.
  5. Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res 2010;23:1-5. [PubMed abstract]
  6. Gibson, RS. Principles of Nutritional Assessment, 2nd ed. New York, NY: Oxford University Press, 2005.
  7. Witkowski M, Hubert J, Mazur A. Methods of assessment of magnesium status in humans: a systematic review. Magnesium Res 2011;24:163-80. [PubMed abstract]
  8. Azoulay A, Garzon P, Eisenberg MJ. Comparison of the mineral content of tap water and bottled waters. J Gen Intern Med 2001;16:168-75. [PubMed abstract]
  9. Fine KD, Santa Ana CA, Porter JL, Fordtran JS. Intestinal absorption of magnesium from food and supplements. J Clin Invest 1991;88:396-402. [PubMed abstract]
  10. U.S. Department of Agriculture, Agricultural Research Service. FoodData Central, 2019.
  11. U.S. Food and Drug Administration. Food Labeling: Revision of the Nutrition and Supplement Facts Labels. 2016.
  12. Ranade VV, Somberg JC. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther 2001;8:345-57. [PubMed abstract]
  13. Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnes Res 2001;14:257-62. [PubMed abstract]
  14. Mühlbauer B, Schwenk M, Coram WM, Antonin KH, Etienne P, Bieck PR, Douglas FL. Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers. Eur J Clin Pharmacol 1991;40:437-8. [PubMed abstract]
  15. Lindberg JS, Zobitz MM, Poindexter JR, Pak CY. Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr 1990;9:48-55. [PubMed abstract]
  16. Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomized, double-blind study. Mag Res 2003;16:183-91. [PubMed abstract]
  17. Spencer H, Norris C, Williams D. Inhibitory effects of zinc on magnesium balance and magnesium absorption in man. J Am Coll Nutr 1994;13:479-84. [PubMed abstract]
  18. Guerrera MP, Volpe SL, Mao JJ. Therapeutic uses of magnesium. Am Fam Physician 2009;80:157-62. [PubMed abstract]
  19. Phillips’®. Phillips’ Milk of Magnesia. 2020.
  20. Rolaids®. 2012.
  21. Tums®. 2012.
  22. U.S. Department of Agriculture, Agricultural Research Service. Usual Nutrient Intake from Food and Beverages, by Gender and Age, What We Eat in America, NHANES 2013-2016; 2019.
  23. Bailey RL, Fulgoni III VL, Keast DR, Dwyer JD. Dietary supplement use is associated with high intakes of minerals from food sources. Am J Clin Nutr 2011;94:1376-81. [PubMed abstract]
  24. Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev 2012;70:153-64. [PubMed abstract]
  25. Chaudhary DP, Sharma R, Bansal DD. Implications of magnesium deficiency in type 2 diabetes: a review. Biol Trace Elem Res 2010;134:119–29. [PubMed abstract]
  26. Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med 1996;156:1143-8. [PubMed abstract]
  27. Rivlin RS. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr 1994;13:416–23. [PubMed abstract]
  28. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of U.S. adults. J Nutr 2003;133:2879-82. [PubMed abstract]
  29. Musso CG Magnesium metabolism in health and disease. Int Urol Nephrol 2009;41:357-62. [PubMed abstract]
  30. Barbagallo M, Belvedere M, Dominguez LJ. Magnesium homeostasis and aging. Magnes Res 2009;22:235-46. [PubMed abstract]
  31. Dickinson HO, Nicolson D, Campbell F, Cook JV, Beyer FR, Ford GA, Mason J. Magnesium supplementation for the management of primary hypertension in adults. Cochrane Database of Systematic Reviews 2006: CD004640. [PubMed abstract]
  32. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012;66:411-8. [PubMed abstract]
  33. Champagne CM. Dietary interventions on blood pressure: the Dietary Approaches to Stop Hypertension (DASH) trials. Nutr Rev 2006;64:S53-6. [PubMed abstract]
  34. U.S. Food and Drug Administration. RE: Petition for a qualified health claim for magnesium and reduced risk of high blood pressure (hypertension) (docket No. FDA-2016-Q-3770). January 10, 2022.
  35. Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom AR. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2010;160:464-70. [PubMed abstract]
  36. Chiuve SE, Korngold EC, Januzzi Jr JL, Gantzer ML, Albert CM. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 2011;93:253-60. [PubMed abstract]
  37. Joosten MM, Gansevoort RT, Mukamal KJ, van der Harst P, Geleijnse JM, Feskens EJM, Navis G, Bakker SJL. Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr 2013;97:1299-306. [PubMed abstract]
  38. Del Gobbo LC, Imamura F, Wu JHY, Otto MCdO, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 2013;98:160-73. [PubMed abstract]
  39. Larsson SC, Orsini N, Wolk A. Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr 2012;95:362-6. [PubMed abstract]
  40. Song Y, Liu S. Magnesium for cardiovascular health: time for intervention. Am J Clin Nutr 2012;95:269-70. [PubMed abstract]
  41. Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med 2007;262:208-14. [PubMed abstract]
  42. Rodriguez-Moran M, Simental Mendia LE, Zambrano Galvan G, Guerrero-Romero F. The role of magnesium in type 2 diabetes: a brief based-clinical review. Magnes Res 2011;24:156-62. [PubMed abstract]
  43. Simmons D, Joshi S, Shaw J. Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract 2010;87:261-6. [PubMed abstract]
  44. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 2007;167:956–65. [PubMed abstract]
  45. Dong J-Y, Xun P, He K, Qin L-Q. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 2011;34:2116-22. [PubMed abstract]
  46. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2013;36:3821-42. [PubMed abstract]
  47. Lima MDL, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Canguco V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998;21:682-6. [PubMed abstract]
  48. Rodriquez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003;26:1147-52. [PubMed abstract]
  49. de Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, Struyvenberg A. Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients. Diabet Med 1998;15:503-7 [PubMed abstract]
  50. Rude RK, Singer FR, Gruber HE. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009;28:131–41. [PubMed abstract]
  51. Tucker KL. Osteoporosis prevention and nutrition. Curr Osteoporos Rep 2009;7:111-7. [PubMed abstract]
  52. Mutlu M, Argun M, Kilic E, Saraymen R, Yazar S. Magnesium, zinc and copper status in osteoporotic, osteopenic and normal post-menopausal women. J Int Med Res 2007;35:692-5. [PubMed abstract]
  53. Aydin H, Deyneli O, Yavuz D, Gözü H, Mutlu N, Kaygusuz I, Akalin S. Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Biol Trace Elem Res 2010;133:136-43. [PubMed abstract]
  54. Sun-Edelstein C, Mauskop A. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother 2009;9:369–79 [PubMed abstract]
  55. Schürks M, Diener H-C, Goadsby P. Update on the prophylaxis of migraine. Cur Treat Options Neurol 2008;10:20–9. [PubMed abstract]
  56. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Neurology 2012;78:1346-53. [PubMed abstract]
  57. Natural Medicines Comprehensive Database. Magnesium. 2013.
  58. Kutsal E, Aydemir C, Eldes N, Demirel F, Polat R, Taspnar O, Kulah E. Severe hypermagnesemia as a result of excessive cathartic ingestion in a child without renal failure. Pediatr Emerg Care 2007;23:570-2. [PubMed abstract]
  59. McGuire JK, Kulkarni MS, Baden HP. Fatal hypermagnesemia in a child treated with megavitamin/megamineral therapy. Pediatrics 2000;105:E18. [PubMed abstract]
  60. Onishi S, Yoshino S. Cathartic-induced fatal hypermagnesemia in the elderly. Intern Med 2006;45:207-10. [PubMed abstract]
  61. Dunn CJ, Goa KL. Risedronate: A review of its pharmacological properties and clinical use in resorptive bone disease. Drugs 2001;61:685-712. [PubMed abstract]
  62. Arayne MS, Sultana N, Hussain F. Interactions between ciprofloxacin and antacids–dissolution and adsorption studies. Drug Metabol Drug Interact 2005;21:117-29. [PubMed abstract]
  63. Sarafidis PA, Georgianos PI, Lasaridis AN. Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy. Expert Opin Drug Saf 2010;9:259-73. [PubMed abstract]
  64. U.S. Food and Drug Administration. Proton Pump Inhibitor Drugs (PPIs): Drug Safety Communication—Low Magnesium Levels Can Be Associated With Long-Term Use. March 2, 2011.

Disclaimer

Updated: January 6, 2026 History of changes to this fact sheet

Drax stop burning wood Pellets – saving forests

March 12, 2026

Muslim Welfare Center – Charity &Women Care

Support Women & Children In Need

Native Canadians – or Genocide Narratives

More than 1.8 million Indigenous people

Why is European Blood so Unique? –

Celtic History Decoded

Fasting – Verses -Islam

FASTING

Purpose of Fasting -To Attain Piety

Allah (SWT) says in the Quran: 

Surah Baqarah – Verses

FASTING IS A SHIELD(From Hellfire)

Narrated Abu Huraira:

Hadith – Sahih al Bukhari 1894;

the Gate of Ar-Raiyan

Narrated Sahl:

Key Hadith on Fasting:

It was narrated from Abu Hurairah that the Messenger of Allah (ﷺ) said:

The Relationship between Water Availability and First Nations Sucide Rates

Abstract

Ansloos, J., & Cooper, A. (2023). Is suicide a water justice issue? Investigating long-term drinking water advisories and suicide in First Nations in Canada. International Journal of Environmental Research and Public Health, 20(5), 4045.

1. Introduction

1.1. Suicide among First Nations in Canada

Protect Canada’s Forests

If you found out that at least $200 million of public funding went towards a single major corporation and its subsidiaries over the last few years, would you have questions about its operations? What if I told you they also managed 22 million hectares of forest across Canada [1]? Furthermore, what if they had global ties to a corporation with a documented track record of environmental and human rights violations [2]? Our brand new reports highlight the concerning lack of transparency and accountability surrounding the company that has been establishing itself as a logging giant across Canada for the last two decades: Domtar, formerly known as Paper Excellence and Resolute.
Forests are living, breathing systems that sustain life, not just resources to be commodified. And now, with the Carney government giving natural resource lobbyists (those hired to speak on behalf of industry behind closed doors) so much access, pushing for transparency and accountability has never been more important [3].
Add your name: Forests deserve answers 
These new reports trace Domtar’s extensive lobbying activity during a critical four-year period, when the company (operating under different names) was facing growing public scrutiny, attempting to silence us through legal action, and approaching a federal investigation [4, 5, 6].  Despite clear rebranding and a carefully crafted “green” image [7], serious transparency gaps remain. Domtar’s sole owner, Jackson Wijaya, has still not appeared before the House of Commons Committee—even after being formally requested to do so [8]. Canadians are being left in the dark about who truly controls the largest forestry company in the country [9] and what that control means for the future of forests and communities.
What the reports reveal is deeply concerning: The research shows that as Domtar ramped up lobbying ahead of federal scrutiny, it received over $200 million in public funding while facing environmental penalties and mill closures—raising serious questions about transparency and public benefit. This all reveals a stark imbalance: vast amounts of political access and public money flowing to one company, with too little transparency in return—at a moment when Canada’s forests are already under intense pressure from industrial logging, old growth logging, biodiversity loss, and a rapidly changing climate [10, 11, 12].
That’s why we’re calling on Domtar’s owner, Jackson Wijaya, to appear before the House of Commons Committee and fully cooperate with its work. Canadians deserve clear, public answers about who controls Domtar, what the company’s long-term plans are, and what its expansion means for the future of forests and forest-based communities across Canada.
 Will you now add your name to demand transparency and accountability from the logging giant that’s been taking over forests across Canada?

ODSB – Ontario Disability Support Application

Ontario Disability Support Program

Who qualifies

Prescribed classes

Learn more about prescribed classes.

ODSB – Medical Review Package

Overview

NumberISP1151
TitleApplication kit for Canada Pension Plan Disability benefits
PurposeTo apply for a Canada Pension Plan Disability benefit. Information in the application form describes the benefits that may be available to you and any dependent children you may have. It is important that you read the instructions and answer the questions with as much detail as possible. The application kit includes: 1. Application for a Canada Pension Plan Disability Benefit (ISP-1151) 2. Medical Report for a Canada Pension Plan Disability Benefit (ISP-2519)
GroupCanada Pension Plan

US Gun Violence – Stats

Statistics- Wikepedia

Stats – AA Turkey Press

PROTECTION FROM MAGIC- DUAHS/ PRAYERS

Surah Al-Falaq and Al-Naas

SURAHS – QURAN CHAPTERS

Bewitchment of the Prophet (Peace be upon Him)

SURAH AL-FALAQ/ DAYBREAK – CH113

SURAH AN-NAAS – CH114 – THE PEOPLE – QURAN KAREEM